Cite
[Differential population screening and efficacy analysis of (125)I implantation after radiofrequency ablation of primary liver cancer]
MLA
X H, Ying, et al. “[Differential Population Screening and Efficacy Analysis of (125)I Implantation after Radiofrequency Ablation of Primary Liver Cancer].” Zhonghua Yi Xue Za Zhi, vol. 100, no. 17, May 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........440d67199e9cf5879306b23e05524f48&authtype=sso&custid=ns315887.
APA
X H, Y., D K, Z., L, C., F Z, W., L Q, L., J J, S., Q Y, W., J F, T., & J S, J. (2020). [Differential population screening and efficacy analysis of (125)I implantation after radiofrequency ablation of primary liver cancer]. Zhonghua Yi Xue Za Zhi, 100(17).
Chicago
X H, Ying, Zhang D K, Chen L, Wu F Z, Lai L Q, Song J J, Weng Q Y, Tu J F, and Ji J S. 2020. “[Differential Population Screening and Efficacy Analysis of (125)I Implantation after Radiofrequency Ablation of Primary Liver Cancer].” Zhonghua Yi Xue Za Zhi 100 (17). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........440d67199e9cf5879306b23e05524f48&authtype=sso&custid=ns315887.